Management of Drop (Atonic) Seizures
For drop attacks in Lennox-Gastaut syndrome and similar epilepsies, use topiramate (6 mg/kg/day) or lamotrigine (50-400 mg/day adjusted for weight and valproate use) as first-line maintenance therapy, with valproic acid as an alternative initial option 1.
Acute Management
For any drop seizure evolving into status epilepticus or prolonged seizure activity:
- Benzodiazepines are the first-line acute treatment 2, 3
- Administer via IV, intramuscular, rectal, or intranasal routes
- Short-acting benzodiazepines are preferred 4
- Time-critical intervention: initiate immediately to prevent progression
If seizures persist after benzodiazepines:
- Second-line options include phenytoin/fosphenytoin, valproate, or levetiracetam 2
- These three agents show similar efficacy (approximately 50% seizure cessation) 2
- For refractory cases, IV anesthetics including ketamine are necessary 2
First-Line Maintenance Treatment
Level A Evidence (Strongest Recommendations)
Topiramate and lamotrigine are the only medications with Level A evidence for drop attacks 1:
Topiramate: 6 mg/kg/day
- Demonstrated 14% reduction in drop attacks versus 5.1% increase with placebo
- 55% of patients achieved 50% responder rate in open-label follow-up
- 56% median reduction in drop attacks 1
Lamotrigine: 50-400 mg/day (dose-adjusted for weight and valproate co-administration)
- Effective in reducing seizures in Lennox-Gastaut syndrome
- Critical caveat: 9% rash rate, including serious cases and Stevens-Johnson syndrome in pediatric patients 1
- Requires slow titration, especially with valproate
Alternative First-Line Options
Valproic acid is widely used in clinical practice:
- 77% of pediatric neurologists in Saudi Arabia use it as first-line 5
- Broad-spectrum efficacy for generalized epilepsies
- Important limitation: Category D teratogenicity (both animal and human evidence) 1
Levetiracetam is increasingly favored:
- Commonly included in initial management protocols 5
- Better safety profile than older agents
- No Level A evidence specifically for drop attacks, but widely used based on clinical experience
Clinical Decision Algorithm
Step 1: Confirm drop attack type
- True atonic seizures are rare; most are epileptic spasms or seizures with increased muscle tone 6
- Video-EEG-EMG monitoring provides accurate diagnosis when feasible
Step 2: Choose initial maintenance therapy based on:
- Lennox-Gastaut syndrome confirmed: Topiramate or lamotrigine (Level A) 1
- Female of childbearing potential: Avoid valproate; prefer topiramate or lamotrigine
- Concern for rash/Stevens-Johnson: Avoid lamotrigine; use topiramate or valproate
- Rapid titration needed: Levetiracetam or valproate (lamotrigine requires slow titration)
Step 3: Add adjunctive therapy if monotherapy fails:
Step 4: Surgical evaluation for drug-resistant cases:
- Corpus callosotomy is effective for refractory epileptic drop attacks, especially in Lennox-Gastaut syndrome 6, 8
- Total callosotomy shows favorable seizure cessation rates in bilateral malformations of cortical development 8
Critical Pitfalls to Avoid
- Do not use carbamazepine: Known to cause seizure worsening in Lennox-Gastaut syndrome and generalized epilepsies 1
- Do not delay lamotrigine titration: Rapid titration increases Stevens-Johnson syndrome risk
- Do not assume all drop attacks are atonic: Most are epileptic spasms requiring different pathophysiologic consideration 6
- Do not use general anesthesia for continuous partial epilepsy 9
Evidence Quality Considerations
The strongest evidence comes from the 2004 AAN/AES guidelines 1, which provide Level A recommendations based on Class I studies. While older, these remain the only Level A evidence specifically for drop attacks. The 2024 status epilepticus guidelines 9 inform acute management but don't specifically address chronic drop attack treatment. Recent observational data 5 shows real-world practice patterns but lacks the rigor of controlled trials. The paucity of recent high-quality trials for drop attacks means we must rely on this older but methodologically sound evidence 1.